SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000893838-05-000149
Filing Date
2005-05-23
Accepted
2005-05-23 16:25:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 rex13dckd.txt SC 13D 15010
2 poackd.txt EX-2 2436
  Complete submission text file 0000893838-05-000149.txt   19561
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Subject) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-79996 | Film No.: 05851537
SIC: 2834 Pharmaceutical Preparations

Mailing Address 368 3-GA CHUNGJEONG-RO SEODAEMUN-GU CPO BOX 3477 SEOUL M5 120-756
Business Address 368 3-GA CHUNGJEONG-RO SEODAEMUN-GU CPO BOX 3477 SEOUL M5 120-756 82-2-2194-0395
Chong Kun Dang Pharmaceutical Corp. (Filed by) CIK: 0001317330 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M5 | Fiscal Year End: 1231
Type: SC 13D